Leucettinib-21
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Leucettinib-21, covering 2025-12-10 to 2025-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease [Phase 1]